2. Gene
  3. Lta - lymphotoxin A Gene

Lta - lymphotoxin A Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Mus musculus

Also known as LT; Ltx; Tnfb; LT[a]; LT-[a]; TNFSF1; Tnlg1e; hlb382; LTalpha; Tnfsf1b; LT-alpha; TNF-beta

Gene ID: 16992 | Gene type: protein coding

About Lta

Chromosome 17: 35,422,141-35,424,327 reverse strand.GRCm39:CM001010.3

This gene has 1 transcript (splice variant), 239 orthologues, 8 paralogues and is associated with 96 phenotypes. Biased expression in spleen adult (RPKM 15.), mammary gland adult (RPKM 7.3) and 2 other tissues.

Summary

Predicted to enable tumor necrosis factor receptor binding activity. Acts upstream of or within several processes, including lymph node development; positive regulation of immune response; and positive regulation of interferon-gamma production. Predicted to be located in extracellular space. Is expressed in several structures, including extraembryonic component; gut; hemolymphoid system; liver; and reproductive system. Human ortholog(s) of this gene implicated in several diseases, including artery disease (multiple); autoimmune disease (multiple); glucose metabolism disease (multiple); leishmaniasis (multiple); and lung disease (multiple). Orthologous to human LTA (lymphotoxin alpha). [provided by Alliance of Genome Resources, Apr 2022]

Lta Products(1)

mRNA Protein Name
NM_010735.2 NP_034865.1 lymphotoxin-alpha precursor

Lta Protein Structure

TNF

TNF: pfam00229 (73 - 201)

  • 0
  • 100
  • 202 a.a.
Protein Preferred Names Protein Names

lymphotoxin-alpha

TNF beta

tumor necrosis factor ligand 1e

tumor necrosis factor ligand superfamily member 1

Recombinant Lta Proteins

Cat. No. Product Name Accession Purity
HY-P700228AF Animal-Free TNF beta Protein, Mouse (His) P09225 (L34-L202) ≥95%

Related Agents

Approval
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0494 Bufexamac Inhibitor ≥98.0% Unkown
Clinical Phase
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P99309 Pagibaximab Inhibitor 98.81% Phase 3
Pre-clinical Phase
Bioactive Molecules (30)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-103226 SC-57461A Inhibitor 99.89% Unkown
HY-W074890 Palmitoylglycine Modulator 99.74% Unkown
HY-137298 LTA4H-IN-1 Inhibitor 98.61% Unkown
HY-135813 LtaS-IN-1 Inhibitor 95.05% Unkown
HY-164051 1650-M15 Inhibitor 99.33% Unkown
HY-113446S Leukotriene C4-d5 97.9% Unkown
HY-125770 5(S)​-​HPETE ≥98.0% Unkown
HY-W004291 Methyl arachidate Inhibitor ≥98.0% Unkown
HY-10826 DG051 free acid Inhibitor / Unkown
HY-112621 Leukotriene A4 methyl ester / Unkown
HY-118795 SC-22716 Inhibitor / Unkown
HY-130441 Leukotriene B3 / Unkown
HY-146811 HSGN-94 Inhibitor / Unkown
HY-149801A Antibacterial agent 140 chloride Inhibitor / Unkown
HY-156960 JNJ-40929837 Inhibitor / Unkown
HY-156960A JNJ-40929837 succinate Inhibitor / Unkown
HY-160646 LTA4H-IN-3 Inhibitor / Unkown
HY-161349 LTA4H-IN-4 Inhibitor / Unkown
HY-162710 LTA4H-IN-5 Inhibitor / Unkown
HY-163336 14,15-Leukotriene A4 methyl ester / Unkown
HY-N8760 Batatasin IV Inhibitor / Unkown
HY-RS07868 LTA Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS07869 Lta Mouse Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS07870 LTA Rat Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS07871 LTA4H Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-W004291R Methyl arachidate (Standard) Inhibitor / Unkown
HY-10320A Doramapimod hydrochloride Inhibitor / Unkown
HY-129461 Dibenzyl trisulfide Inducer / Unkown
HY-156416 LtaS-IN-2 Inhibitor / Unkown
HY-162015 LTA4H-IN-2 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Lta NCBI NCBI:4049
Canis familiaris Lta NCBI NCBI:607183
Macaca fascicularis Lta NCBI NCBI:102138497
Rattus norvegicus Lta NCBI NCBI:25008
Macaca mulatta Lta NCBI NCBI:715425